Want to see IMCC full AI Analyst Report?
IMCC Stock Chart & Stats
$1.44
-$0.13(-4.96%)
At close: 4:00 PM EST
$1.44
-$0.13(-4.96%)
Day’s Range― - ―
52-Week Range$0.12 - $3.61
Previous Close$2.49
Volume28.72K
Average Volume (3M)72.27K
Market Cap
$1.28M
Enterprise Value$12.04
Total Cash (Recent Filing)$1.15M
Total Debt (Recent Filing)$14.95M
Price to Earnings (P/E)―
Beta1.50
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-282.07
Shares Outstanding9,016,539
10 Day Avg. Volume74,089
30 Day Avg. Volume72,265
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-9.42
Price to Sales (P/S)0.15
P/FCF Ratio1.72
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$62.75M
Bulls Say, Bears Say
Bulls Say
Regulated Medical Market FocusIM Cannabis operates in regulated medical markets (Israel and Germany) with multi-channel distribution (import, pharmacies, online). That structural focus on prescription patients and data-driven patient insights supports more predictable demand, reimbursement access and long-term revenue stability vs informal markets.
Cost Reductions And Expense ControlManagement narrowed the cost base with a 22% cut in G&A and stated ongoing cost optimization. Sustained expense discipline can materially improve operating leverage, extend runway and make the business more resilient to revenue variability, increasing the odds of reaching sustained profitability.
Planned Debt Reduction Via Asset SaleA proposed sale of European assets that would transfer ~C$10.5M of liabilities would meaningfully reduce leverage and simplify operations. If completed, de-leveraging and a tighter geographic focus should improve liquidity, reduce interest and restructuring burden, and allow capital to be redeployed to core markets.
Bears Say
Negative Shareholders' EquityThe transition to negative equity materially weakens the balance sheet, limiting borrowing capacity and increasing covenant/default risk. Negative equity distorts leverage metrics, constrains strategic flexibility, and typically forces companies toward dilutive financings or asset sales to repair capital structure over the medium term.
Return To Cash BurnA reversion from positive to negative operating and free cash flow signals inconsistent cash generation and reduces funding runway. Persistent cash burn elevates refinancing risk, pressures liquidity planning and makes the company dependent on external capital or asset dispositions to sustain operations over the coming months.
Reliance On Convertible FinancingsFrequent convertible notes and warrants create predictable dilution and a complicated capital structure. Heavy reliance on equity-linked financings signals limited access to non-dilutive capital, can erode existing shareholders' value and may deter long-term institutional investors seeking stable governance and predictable equity stakes.
IM Cannabis Corp News
IMCC FAQ
What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $0.12 and its highest was $3.61 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $1.28M.
When is IM Cannabis Corp’s upcoming earnings report date?
IM Cannabis Corp’s upcoming earnings report date is Aug 17, 2026 which is in 30 days.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on May 13, 2026. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is IM Cannabis Corp overvalued?
According to Wall Street analysts IM Cannabis Corp’s price is currently Overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 9,016,539 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$0.28 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.187%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IM Cannabis Corp
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Technical Analysis
Ownership Overview
11.90% Insiders
0.23% Other Institutional Investors
87.87% Public Companies and
Individual Investors